Johnson & Johnson vs Tenet Healthcare Corporation New
JNJ vs THC — side-by-side comparison from reported financials. JNJ leads 6, THC leads 4 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Tenet Healthcare Corporation New
THC · Healthcare
$264.31+1.44%Mixed
| Metric | JNJ | THC |
|---|---|---|
| Price | $261.79 | $264.31 |
| Market cap | $631B | $21.3B |
| Revenue (TTM) | $97.9B | $21.8B |
| Revenue growth | +5.6% | +3.6% |
| Net margin | 21.5% | 10.3% |
| Free cash flow | $22.2B | $3.02B |
| Net cash (debt) | ($27.8B) | ($10.3B) |
| 1-year price return | +37.0% | +35.6% |
| P/E | 29.9 | 9.5 |
| P/E vs own history (cheap-side %) | 16% | 50% |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | 51% |
| Altman Z-score | — | 1.51 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 140,800 | 99,000 |
Full résumé-style profiles: JNJ CV · THC CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.